Notably, higher expressions of CTLA4 and PD1 were associated with improved survival, while higher TIL load correlated with CTLA4, HAVCR2 (TIM-3), LAG3, and CD274 (PD-L1) expressions in colon adenocarcinoma. Here, CD274 is linked to colon adenocarcinoma.